Published in Neurosurgery on March 01, 1995
Abnormal activation of the primary somatosensory cortex in spasmodic dysphonia: an fMRI study. Cereb Cortex (2010) 1.09
Movement disorders after stroke in adults: a review. Tremor Other Hyperkinet Mov (N Y) (2012) 0.97
The treatment of movement disorders by deep brain stimulation. Neurotherapeutics (2008) 0.96
Alternative approaches to modeling hereditary dystonias. Neurotherapeutics (2012) 0.81
Current and future medical treatment in primary dystonia. Ther Adv Neurol Disord (2012) 0.79
Cervical Dystonia (Torticollis). Curr Treat Options Neurol (1999) 0.77
Thalamic post-inhibitory bursting occurs in patients with organic dystonia more often than controls. Brain Res (2013) 0.76
Previous Injury and Chronic Pain are Associated with Side of Onset in Parkinson's Disease. J Neurol Neurobiol (2015) 0.75
Sensory, Motor and Intrinsic Mechanisms of Thalamic Activity related to Organic and Psychogenic Dystonia. J Alzheimers Dis Parkinsonism (2017) 0.75
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology (1996) 8.82
Immunization against rubella. A study to determine the place of rubella vaccination as a selective procedure in a comprehensive immunization programme. Practitioner (1971) 3.50
Excess of non-parental bands in offspring from known primate pedigrees assayed using RAPD PCR. Nucleic Acids Res (1992) 3.10
Hemiballism-hemichorea. Clinical and pharmacologic findings in 21 patients. Arch Neurol (1989) 2.91
Essential tremor: clinical correlates in 350 patients. Neurology (1991) 2.89
Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA (2001) 2.79
Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology (2004) 2.70
The Galveston Orientation and Amnesia Test. A practical scale to assess cognition after head injury. J Nerv Ment Dis (1979) 2.69
The morbidity and mortality of vermiculite miners and millers exposed to tremolite-actinolite: Part I. Exposure estimates. Am J Ind Med (1987) 2.66
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology (2003) 2.65
Paroxysmal kinesigenic dyskinesia and infantile convulsions: clinical and linkage studies. Neurology (2000) 2.48
Psychogenic myoclonus. Neurology (1993) 2.39
Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology (1987) 2.38
The impact of depressive symptoms in early Parkinson disease. Neurology (2007) 2.37
Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA (2001) 2.36
Effect of head elevation on intracranial pressure, cerebral perfusion pressure, and cerebral blood flow in head-injured patients. J Neurosurg (1992) 2.32
Cerebral arteriovenous oxygen difference as an estimate of cerebral blood flow in comatose patients. J Neurosurg (1989) 2.32
A statistical analysis of a series of birth-weights and placental weights. Hum Biol (1967) 2.23
Paroxysmal dyskinesias: clinical features and classification. Ann Neurol (1995) 2.21
Microelectrode-guided posteroventral pallidotomy for treatment of Parkinson's disease: postoperative magnetic resonance imaging analysis. J Neurosurg (1997) 2.15
Delayed-onset progressive movement disorders after static brain lesions. Neurology (1996) 1.96
Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology (2001) 1.94
Continuous monitoring of jugular venous oxygen saturation in head-injured patients. J Neurosurg (1992) 1.92
Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology (1982) 1.88
Hemifacial spasm: clinical findings and treatment. Muscle Nerve (1998) 1.88
Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol (1983) 1.87
Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology (1997) 1.86
Long-term neuropsychological outcome of closed head injury. J Neurosurg (1979) 1.83
Aneurysms of the posterior cerebral artery: classification and endovascular treatment. AJNR Am J Neuroradiol (2001) 1.80
Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol (1998) 1.80
Extrapyramidal involvement in Rett's syndrome. Neurology (1990) 1.74
Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. Neurosurgery (1995) 1.72
Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease. Neurology (2007) 1.68
Prevention of secondary ischemic insults after severe head injury. Crit Care Med (1999) 1.68
Rapamycin protects against rotenone-induced apoptosis through autophagy induction. Neuroscience (2009) 1.67
Near-infrared spectroscopic localization of intracranial hematomas. J Neurosurg (1993) 1.66
The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology (1985) 1.65
The National Traumatic Coma Data Bank. Part 1: Design, purpose, goals, and results. J Neurosurg (1983) 1.63
A variant in the HS1-BP3 gene is associated with familial essential tremor. Neurology (2005) 1.63
The alien hand and related signs. J Neurol Neurosurg Psychiatry (1992) 1.62
Orthostatic tremor: an association with essential tremor. Mov Disord (1991) 1.58
Intrathecal baclofen for intractable axial dystonia. Neurology (1991) 1.58
What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study. Neurology (1997) 1.58
Tardive oculogyric crises. Neurology (1989) 1.56
Segmental myoclonus. Clinical and pharmacologic study. Arch Neurol (1986) 1.56
Pallidotomy for generalized dystonia. Mov Disord (1998) 1.54
Hemidystonia: a report of 22 patients and a review of the literature. J Neurol Neurosurg Psychiatry (1985) 1.52
Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology (2001) 1.52
Effects of visual and auditory cues on gait in individuals with Parkinson's disease. J Neurol Sci (2004) 1.50
Bruxism in Huntington's disease. Mov Disord (2000) 1.49
Treatment of palatal myoclonus with sumatriptan. Mov Disord (1996) 1.48
Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci U S A (1994) 1.46
Fog catchment sand trenches constructed by tenebrionid beetles, lepidochora, from the namib desert. Science (1976) 1.46
Metoclopramide-induced movement disorders. Clinical findings with a review of the literature. Arch Intern Med (1989) 1.46
Tardive akathisia: an analysis of clinical features and response to open therapeutic trials. Mov Disord (1989) 1.44
Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia. J Neurosci (1997) 1.43
Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatry (2005) 1.42
Genome-wide association study of Tourette's syndrome. Mol Psychiatry (2012) 1.42
Cervical dystonia as the initial presentation of Huntington's disease. Mov Disord (1996) 1.39
Treating severe bruxism with botulinum toxin. J Am Dent Assoc (2000) 1.38
Blepharospasm associated with brainstem lesions. Neurology (1983) 1.37
Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors. Mol Ther (2000) 1.37
Copulatory vocalizations of chacma baboons (Papio ursinus), gibbons (Hylobates hoolock), and humans. Science (1978) 1.37
What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol (1997) 1.35
The early development of the goat (Capra hircus). J Anat (1942) 1.34
Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology (2005) 1.34
The marmoset as an animal model for teratological research. Nature (1972) 1.34
Association between essential tremor and Parkinson's disease. Ann Neurol (1985) 1.33
Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report. Arch Otolaryngol Head Neck Surg (1987) 1.33
Circulating catecholamines and sympathetic activity after head injury. Neurosurgery (1981) 1.32
Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology (1996) 1.32
Jugular venous desaturation and outcome after head injury. J Neurol Neurosurg Psychiatry (1994) 1.32
Physiologic and pathologic tremors. Diagnosis, mechanism, and management. Ann Intern Med (1980) 1.28
Relationship of aging to Parkinson's disease. Adv Neurol (1987) 1.28
Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology (2004) 1.28
Focal task-specific tremor and dystonia: categorization of occupational movement disorders. Neurology (1988) 1.26
Examination of the SLITRK1 gene in Caucasian patients with Tourette syndrome. Acta Neurol Scand (2006) 1.26
Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry (1998) 1.25
Lower body parkinsonism: evidence for vascular etiology. Mov Disord (1989) 1.24
Low cancer rates among patients with Parkinson's disease. Ann Neurol (1985) 1.24
Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. Neurology (1999) 1.23
Movement disorders and AIDS. Neurology (1987) 1.23
Behavioral sequelae of closed head injury. A quantitative study. Arch Neurol (1978) 1.22
Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury. J Neurochem (1999) 1.21
Late-onset Hallervorden-Spatz disease presenting as familial parkinsonism. Neurology (1985) 1.21
Blinking and blepharospasm. Mechanism, diagnosis, and management. JAMA (1982) 1.19
Stiff-person syndrome: an autoimmune disease. Mov Disord (1991) 1.19
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology (1999) 1.19
Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry (2007) 1.18
Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics (2001) 1.18
Development and structure of the human placenta from the end of the 3rd month of gestation. J Obstet Gynaecol Br Commonw (1967) 1.18
Clinical correlates of vascular parkinsonism. Arch Neurol (1999) 1.18
Herpes zoster ophthalmicus followed by contralateral hemiparesis: report of two cases and review of literature. J Neurol Neurosurg Psychiatry (1985) 1.17
Topiramate in essential tremor: a double-blind, placebo-controlled trial. Neurology (2006) 1.17
Criteria for the diagnosis of essential tremor. Neurology (2000) 1.17